BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Jong S, Gagliardi G, Garanto A, de Breuk A, Lechanteur YTE, Katti S, van den Heuvel LP, Volokhina EB, den Hollander AI. Implications of genetic variation in the complement system in age-related macular degeneration. Prog Retin Eye Res 2021;:100952. [PMID: 33610747 DOI: 10.1016/j.preteyeres.2021.100952] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Santos FM, Mesquita J, Castro-de-sousa JP, Ciordia S, Paradela A, Tomaz CT. Vitreous Humor Proteome: Targeting Oxidative Stress, Inflammation, and Neurodegeneration in Vitreoretinal Diseases. Antioxidants 2022;11:505. [DOI: 10.3390/antiox11030505] [Reference Citation Analysis]
2 Li S, Qiu Y, Yu J, Shao M, Li Y, Cao W, Sun X. Serum complement component 3, complement component 4 and complement component 1q levels predict progressive visual field loss in older women with primary angle closure glaucoma. Br J Ophthalmol 2022:bjophthalmol-2021-320541. [PMID: 35017157 DOI: 10.1136/bjophthalmol-2021-320541] [Reference Citation Analysis]
3 Acar IE, Willems E, Kersten E, Keizer-Garritsen J, Kragt E, Bakker B, Galesloot TE, Hoyng CB, Fauser S, van Gool AJ, Lechanteur YTE, Koertvely E, Nogoceke E, Gloerich J, de Jonge MI, Lorés-Motta L, den Hollander AI. Semi-Quantitative Multiplex Profiling of the Complement System Identifies Associations of Complement Proteins with Genetic Variants and Metabolites in Age-Related Macular Degeneration. J Pers Med 2021;11:1256. [PMID: 34945728 DOI: 10.3390/jpm11121256] [Reference Citation Analysis]
4 Khan AH, Hysi PG, Lotery AJ. At What Age Does Age-Related Macular Degeneration Start? JAMA Ophthalmol 2021;139:1226-7. [PMID: 34647993 DOI: 10.1001/jamaophthalmol.2021.4104] [Reference Citation Analysis]
5 Shinomiya K, Mukai A, Ito E, Yoneda K, Ueno M, Sotozono C, Kinoshita S, Hamuro J. Potential participation of CTRP6, a complement regulator, in the pathology of age related macular degeneration. Jpn J Ophthalmol 2022. [PMID: 35397057 DOI: 10.1007/s10384-022-00913-4] [Reference Citation Analysis]
6 Blasiak J, Hyttinen JMT, Szczepanska J, Pawlowska E, Kaarniranta K. Potential of Long Non-Coding RNAs in Age-Related Macular Degeneration. Int J Mol Sci 2021;22:9178. [PMID: 34502084 DOI: 10.3390/ijms22179178] [Reference Citation Analysis]
7 Qin S, Dong N, Yang M, Wang J, Feng X, Wang Y. Complement Inhibitors in Age-Related Macular Degeneration: A Potential Therapeutic Option. J Immunol Res 2021;2021:9945725. [PMID: 34368372 DOI: 10.1155/2021/9945725] [Reference Citation Analysis]
8 Lin JB, Halawa OA, Miller JW, Vavvas DG. Complement Inhibition for Geographic Atrophy: A Tempting Target with Mixed Results. J Clin Med 2021;10:2890. [PMID: 34209660 DOI: 10.3390/jcm10132890] [Reference Citation Analysis]